Alignment Healthcare (ALHC) EBIT (2020 - 2026)

Alignment Healthcare (ALHC) has reported EBIT for 7 consecutive years, with $42.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, EBIT rose 85.07% year-over-year to $42.1 million; the trailing twelve-month figure through Jun 2026 stood at $55.0 million (up 322.56% YoY), and the FY2025 full-year result was $14.8 million, up 114.53% from the prior year.
• EBIT rose to $42.1 million in Q2 2026 per ALHC's latest filing, from $15.5 million in the prior quarter.
• Across five years, EBIT topped out at $42.1 million in Q2 2026 and bottomed at -$52.1 million in Q4 2022.
• Historically, EBIT has averaged -$15.9 million across 5 years, with a median of -$21.0 million in 2024.
• The sharpest annual moves came in 2023 and 2026: EBIT sank 255.88% in 2023, then jumped 387.47% in 2026.
• Over 5 years, EBIT stood at -$52.1 million in 2022, then increased by 19.56% to -$41.9 million in 2023, then jumped by 46.21% to -$22.5 million in 2024, then jumped by 54.38% to -$10.3 million in 2025, then jumped by 509.37% to $42.1 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $42.1 million, $15.5 million, and -$10.3 million for Q2 2026, Q1 2026, and Q4 2025 respectively.